Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens

H9N2 subtype low pathogenicity avian influenza virus (LPAIV) is distributed worldwide and causes enormous economic losses in the poultry industry. Despite immunization of almost all chickens with inactivated vaccines, the disease still remains widespread. We speculated that improving mucosal or cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Sha, Zhou, Shang, Hongqi, Miao, Yongqiang, Huang, Jin, Niu, Xiangyun, Chen, Ruichang, Hu, Liping, Huang, He, Wei, Kai, Zhu, Ruiliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105734/
https://www.ncbi.nlm.nih.gov/pubmed/32266297
http://dx.doi.org/10.3389/fvets.2020.00153
_version_ 1783512462317846528
author Sha, Zhou
Shang, Hongqi
Miao, Yongqiang
Huang, Jin
Niu, Xiangyun
Chen, Ruichang
Hu, Liping
Huang, He
Wei, Kai
Zhu, Ruiliang
author_facet Sha, Zhou
Shang, Hongqi
Miao, Yongqiang
Huang, Jin
Niu, Xiangyun
Chen, Ruichang
Hu, Liping
Huang, He
Wei, Kai
Zhu, Ruiliang
author_sort Sha, Zhou
collection PubMed
description H9N2 subtype low pathogenicity avian influenza virus (LPAIV) is distributed worldwide and causes enormous economic losses in the poultry industry. Despite immunization of almost all chickens with inactivated vaccines, the disease still remains widespread. We speculated that improving mucosal or cellular immune responses could contribute to improved control of H9N2 viruses. In this study, we constructed a novel Lactococcus lactis (L. lactis) strain expressing a recombinant fusion protein consisting of the M1 and HA2 proteins derived from an antigenically conserved endemic H9N2 virus strain. The M1-HA2 fusion protein was cloned downstream of a gene encoding a secretory peptide, and we subsequently confirmed that the fusion protein was secreted from L. lactis by Western blotting. We assessed the immunogenicity and protective effects of this recombinant L. lactis strain. Eighty 1-day-old chickens were divided into four groups, and the experimental groups were orally vaccinated twice with the recombinant L. lactis strain. Fecal and intestinal samples, sera, and bronchoalveolar lavage fluid were collected at 7, 14, and 21 days post-vaccination (dpv). Chickens vaccinated with the recombinant L. lactis strain showed significantly increased levels of serum antibodies, T cell-mediated immune responses, and mucosal secretory IgA (SIgA). Following challenge with H9N2 virus at 21 dpv, chickens vaccinated with the recombinant L. lactis strain showed decreased weight loss, lower viral titers in the lung, and reduced lung pathological damage. In summary, our results demonstrated that a recombinant L. lactis strain expressing an H9N2 M1-HA2 fusion protein could induce protective mucosal and systemic immunity. This oral vaccine is H9N2 virus-specific and represents a significant design improvement compared with previous studies. Our study provides a theoretical basis for improving mucosal immune responses to prevent and control H9N2 virus infection.
format Online
Article
Text
id pubmed-7105734
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71057342020-04-07 Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens Sha, Zhou Shang, Hongqi Miao, Yongqiang Huang, Jin Niu, Xiangyun Chen, Ruichang Hu, Liping Huang, He Wei, Kai Zhu, Ruiliang Front Vet Sci Veterinary Science H9N2 subtype low pathogenicity avian influenza virus (LPAIV) is distributed worldwide and causes enormous economic losses in the poultry industry. Despite immunization of almost all chickens with inactivated vaccines, the disease still remains widespread. We speculated that improving mucosal or cellular immune responses could contribute to improved control of H9N2 viruses. In this study, we constructed a novel Lactococcus lactis (L. lactis) strain expressing a recombinant fusion protein consisting of the M1 and HA2 proteins derived from an antigenically conserved endemic H9N2 virus strain. The M1-HA2 fusion protein was cloned downstream of a gene encoding a secretory peptide, and we subsequently confirmed that the fusion protein was secreted from L. lactis by Western blotting. We assessed the immunogenicity and protective effects of this recombinant L. lactis strain. Eighty 1-day-old chickens were divided into four groups, and the experimental groups were orally vaccinated twice with the recombinant L. lactis strain. Fecal and intestinal samples, sera, and bronchoalveolar lavage fluid were collected at 7, 14, and 21 days post-vaccination (dpv). Chickens vaccinated with the recombinant L. lactis strain showed significantly increased levels of serum antibodies, T cell-mediated immune responses, and mucosal secretory IgA (SIgA). Following challenge with H9N2 virus at 21 dpv, chickens vaccinated with the recombinant L. lactis strain showed decreased weight loss, lower viral titers in the lung, and reduced lung pathological damage. In summary, our results demonstrated that a recombinant L. lactis strain expressing an H9N2 M1-HA2 fusion protein could induce protective mucosal and systemic immunity. This oral vaccine is H9N2 virus-specific and represents a significant design improvement compared with previous studies. Our study provides a theoretical basis for improving mucosal immune responses to prevent and control H9N2 virus infection. Frontiers Media S.A. 2020-03-24 /pmc/articles/PMC7105734/ /pubmed/32266297 http://dx.doi.org/10.3389/fvets.2020.00153 Text en Copyright © 2020 Sha, Shang, Miao, Huang, Niu, Chen, Hu, Huang, Wei and Zhu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Sha, Zhou
Shang, Hongqi
Miao, Yongqiang
Huang, Jin
Niu, Xiangyun
Chen, Ruichang
Hu, Liping
Huang, He
Wei, Kai
Zhu, Ruiliang
Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens
title Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens
title_full Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens
title_fullStr Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens
title_full_unstemmed Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens
title_short Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens
title_sort recombinant lactococcus lactis expressing m1-ha2 fusion protein provides protective mucosal immunity against h9n2 avian influenza virus in chickens
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105734/
https://www.ncbi.nlm.nih.gov/pubmed/32266297
http://dx.doi.org/10.3389/fvets.2020.00153
work_keys_str_mv AT shazhou recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens
AT shanghongqi recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens
AT miaoyongqiang recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens
AT huangjin recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens
AT niuxiangyun recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens
AT chenruichang recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens
AT huliping recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens
AT huanghe recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens
AT weikai recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens
AT zhuruiliang recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens